Drug: bevacizumab Quarter: 2016Q3
Total Drug/Injury Combinations: 786 Number of Pages: 40
DRUGNAME | PT | EventCount | |
---|---|---|---|
BEVACIZUMAB | Product use issue | 7 | view events |
Bevacizumab | Small intestinal perforation | 7 | view events |
Bevacizumab | Upper respiratory tract infection | 7 | view events |
Bevacizumab | Acute lymphocytic leukaemia | 6 | view events |
Bevacizumab | Anal fistula | 6 | view events |
Bevacizumab | Anorectal infection | 6 | view events |
BEVACIZUMAB | Anxiety | 6 | view events |
Bevacizumab | Arrhythmia | 6 | view events |
Bevacizumab | Cholangitis | 6 | view events |
Bevacizumab | Depressed level of consciousness | 6 | view events |
BEVACIZUMAB | Dry mouth | 6 | view events |
Bevacizumab | Duodenal perforation | 6 | view events |
BEVACIZUMAB | Dysphonia | 6 | view events |
Bevacizumab | Flatulence | 6 | view events |
Bevacizumab | Gamma-glutamyltransferase increased | 6 | view events |
BEVACIZUMAB | Hypercalcaemia | 6 | view events |
Bevacizumab | Metastases to pleura | 6 | view events |
BEVACIZUMAB | Myalgia | 6 | view events |
BEVACIZUMAB | Splenomegaly | 6 | view events |
Bevacizumab | Toxicity to various agents | 6 | view events |
Total Drug/Injury Combinations: 786 Number of Pages: 40
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)